Silver Nanoparticles for Drug Delivery

Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community.

Preface

Part A: Synthesis and characterization of silver nanoparticles
for drug delivery

1. History, introduction, and physicochemical properties of silver nanoparticles

2. Synthesis methods and characterization parameters of silver nanoparticles

Part B: Application of silver nanoparticles in drug delivery

3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery

4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery

5. Silver nanoparticles for cancer diagnosis and treatment of cancer

6. Silver nanoparticles to enhance photodynamic action of photosensitizers

7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm

8. Silver nanoparticles in wound therapy and tissue regeneration

9. Silver nanoparticles for drug delivery in inflammatory bowel disease

10. Silver nanoparticles for the management of neurological diseases

11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements

12. Silver nanoparticles in dentistry

13. Silver nanoparticles and their role in the treatment of endodontic infections

14. Silver nanoparticles for treatment of COVID-19 and other viral diseases

Part C: Recent advances and regulatory aspects of silver nanoparticles

15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles

16. Silver nanoparticleinduced ecotoxicity

17. Clinical translation of silver nanoparticles into the market

18. Conclusion and future prospective of silver nanoparticles